Pharma and Health Care Supply Chains Adjust to State of Disruption
Article from MHI Solutions Magazine
Even in a time marked by disruption and complexity across all supply chains, pharmaceutical and health care supply chains face a notable array of challenges.
“Supply chains remain fragile, vendor solvency risk and product shortages continue, costs are increasing and resiliency is a must,” Christy Christian, senior industry principal at Kinaxis, said. “Disruptions are the norm, and they are coming faster and with more magnitude, introducing more risk and greater urgency for adaptability.”
Perry Fri, chief industry relations officer and president of the HDA Research Foundation, noted that the pharmaceutical supply chain is among the most reliable and tightly regulated industries in the United States. The field is characterized today by policy uncertainty, global trade considerations and a rapidly evolving therapeutic landscape, most notably in specialty, cold‑chain and cell and gene therapies, he said.
Experts from the field shared their insights on the chief challenges and trends shaping the industry today…
